285 related articles for article (PubMed ID: 32668011)
1. Cough as an adverse effect on inhalation pharmaceutical products.
Chang RYK; Kwok PCL; Ghassabian S; Brannan JD; Koskela HO; Chan HK
Br J Pharmacol; 2020 Sep; 177(18):4096-4112. PubMed ID: 32668011
[TBL] [Abstract][Full Text] [Related]
2. Nebulized Mannitol, Particle Distribution, and Cough in Idiopathic Pulmonary Fibrosis.
Kanth PM; Alaienia C; Smaldone GC
Respir Care; 2018 Nov; 63(11):1407-1412. PubMed ID: 30154129
[TBL] [Abstract][Full Text] [Related]
3. Regional sensitivity of human airways to capsaicin-induced cough.
Hansson L; Wollmer P; Dahlbäck M; Karlsson JA
Am Rev Respir Dis; 1992 May; 145(5):1191-5. PubMed ID: 1586064
[TBL] [Abstract][Full Text] [Related]
4. Computationally efficient analysis of particle transport and deposition in a human whole-lung-airway model. Part II: Dry powder inhaler application.
Kolanjiyil AV; Kleinstreuer C; Sadikot RT
Comput Biol Med; 2017 May; 84():247-253. PubMed ID: 27836120
[TBL] [Abstract][Full Text] [Related]
5. Reflex bronchoconstriction evoked by inhaled nicotine aerosol in guinea pigs: role of the nicotinic acetylcholine receptor.
Lee LY; Lin RL; Khosravi M; Xu F
J Appl Physiol (1985); 2018 Jul; 125(1):117-123. PubMed ID: 29369741
[TBL] [Abstract][Full Text] [Related]
6. Post-inhalation cough with therapeutic aerosols: Formulation considerations.
Sahakijpijarn S; Smyth HDC; Miller DP; Weers JG
Adv Drug Deliv Rev; 2020; 165-166():127-141. PubMed ID: 32417367
[TBL] [Abstract][Full Text] [Related]
7. [Chinese expert consensus on standardized inhaler device application in stable chronic airway diseases (2023)].
Inhalation Therapy and Respiratory Rehabilitation Group, Respiratory Equipment Committee of China Association of Medical Equipment
Zhonghua Jie He He Hu Xi Za Zhi; 2023 Nov; 46(11):1055-1067. PubMed ID: 37914418
[TBL] [Abstract][Full Text] [Related]
8. The mechanism of aerosol-induced bronchoconstriction.
Higenbottam T
Bull Eur Physiopathol Respir; 1987; 23 Suppl 10():77s-80s. PubMed ID: 3664027
[TBL] [Abstract][Full Text] [Related]
9. Modelling the effect of charge on selective deposition of particles in a diseased lung using aerosol boli.
Hashish AH; Bailey AG; Williams TJ
Phys Med Biol; 1994 Dec; 39(12):2247-62. PubMed ID: 15551551
[TBL] [Abstract][Full Text] [Related]
10. Regional sensitivity of the respiratory tract to stimuli causing cough and reflex bronchoconstriction.
Karlsson JA; Hansson L; Wollmer P; Dahlbäck M
Respir Med; 1991 Jan; 85 Suppl A():47-50. PubMed ID: 2034835
[TBL] [Abstract][Full Text] [Related]
11. Effect of patient inhalation profile and airway structure on drug deposition in image-based models with particle-particle interactions.
Williams J; Kolehmainen J; Cunningham S; Ozel A; Wolfram U
Int J Pharm; 2022 Jan; 612():121321. PubMed ID: 34875355
[TBL] [Abstract][Full Text] [Related]
12. Use of functional respiratory imaging to characterize the effect of inhalation profile and particle size on lung deposition of inhaled corticosteroid/long-acting β2-agonists delivered via a pressurized metered-dose inhaler.
Van Holsbeke C; De Backer J; Vos W; Marshall J
Ther Adv Respir Dis; 2018; 12():1753466618760948. PubMed ID: 29499614
[TBL] [Abstract][Full Text] [Related]
13. Condensational growth of combination drug-excipient submicrometer particles for targeted high-efficiency pulmonary delivery: evaluation of formulation and delivery device.
Hindle M; Longest PW
J Pharm Pharmacol; 2012 Sep; 64(9):1254-63. PubMed ID: 22881438
[TBL] [Abstract][Full Text] [Related]
14. Flow Structure and Particle Deposition Analyses for Optimization of a Pressurized Metered Dose Inhaler (pMDI) in a Model of Tracheobronchial Airway.
Ahookhosh K; Saidi M; Mohammadpourfard M; Aminfar H; Hamishehkar H; Farnoud A; Schmid O
Eur J Pharm Sci; 2021 Sep; 164():105911. PubMed ID: 34129919
[TBL] [Abstract][Full Text] [Related]
15. Mechanism of cough and bronchoconstriction induced by distilled water aerosol.
Sheppard D; Rizk NW; Boushey HA; Bethel RA
Am Rev Respir Dis; 1983 Jun; 127(6):691-4. PubMed ID: 6407371
[TBL] [Abstract][Full Text] [Related]
16. DT-0111: a novel drug-candidate for the treatment of COPD and chronic cough.
Pelleg A; Xu F; Zhuang J; Undem B; Burnstock G
Ther Adv Respir Dis; 2019; 13():1753466619877960. PubMed ID: 31558105
[TBL] [Abstract][Full Text] [Related]
17. Air and soul: the science and application of aerosol therapy.
Rubin BK
Respir Care; 2010 Jul; 55(7):911-21. PubMed ID: 20587104
[TBL] [Abstract][Full Text] [Related]
18. Pharmaceutical aerosols for the treatment and prevention of tuberculosis.
Hanif SN; Garcia-Contreras L
Front Cell Infect Microbiol; 2012; 2():118. PubMed ID: 22973562
[TBL] [Abstract][Full Text] [Related]
19. Effects of aerosol-applied capsaicin, histamine and prostaglandin E2 on airway sensory receptors of anaesthetized cats.
Mohammed SP; Higenbottam TW; Adcock JJ
J Physiol; 1993 Sep; 469():51-66. PubMed ID: 8271211
[TBL] [Abstract][Full Text] [Related]
20. Validating CFD Predictions of Pharmaceutical Aerosol Deposition with In Vivo Data.
Tian G; Hindle M; Lee S; Longest PW
Pharm Res; 2015 Oct; 32(10):3170-87. PubMed ID: 25944585
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
